Business Description
Innopharmax Inc
NAICS : 325412
SIC : 2834
ISIN : TW0004172002
Description
Innopharmax Inc is a Taiwan based specialty pharmaceutical company. It is focused on the development and commercialization of products for the treatment of oncology and specialty. The company's products include anti-infection agents, contrast agents, oncology agents, immunological agents, drugs for rare diseases and others.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 7.4 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.23 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 22.57 | |||||
Beneish M-Score | 7.19 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -34.3 | |||||
3-Year EBITDA Growth Rate | -22.5 | |||||
3-Year EPS without NRI Growth Rate | -12.7 | |||||
3-Year FCF Growth Rate | 5.7 | |||||
3-Year Book Growth Rate | -6.3 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 41.09 | |||||
9-Day RSI | 45.38 | |||||
14-Day RSI | 47.68 | |||||
6-1 Month Momentum % | 12.35 | |||||
12-1 Month Momentum % | -9.91 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.81 | |||||
Quick Ratio | 3.39 | |||||
Cash Ratio | 3.18 | |||||
Days Inventory | 368.07 | |||||
Days Sales Outstanding | 65.72 | |||||
Days Payable | 158.46 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7 | |||||
Shareholder Yield % | 0.27 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 56.46 | |||||
Operating Margin % | -213.17 | |||||
Net Margin % | -241.45 | |||||
FCF Margin % | -183.33 | |||||
ROE % | -17.59 | |||||
ROA % | -16.18 | |||||
ROIC % | -21.25 | |||||
ROC (Joel Greenblatt) % | -400.08 | |||||
ROCE % | -17.11 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 54.95 | |||||
PB Ratio | 4.38 | |||||
Price-to-Tangible-Book | 4.44 | |||||
EV-to-EBIT | -21.5 | |||||
EV-to-EBITDA | -23.45 | |||||
EV-to-Revenue | 51.72 | |||||
EV-to-FCF | -28.8 | |||||
Price-to-Median-PS-Value | 1.79 | |||||
Price-to-Net-Current-Asset-Value | 16.81 | |||||
Price-to-Net-Cash | 21.98 | |||||
Earnings Yield (Greenblatt) % | -4.65 | |||||
FCF Yield % | -3.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Innopharmax Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 34.589 | ||
EPS (TTM) (NT$) | -0.89 | ||
Beta | 0.39 | ||
Volatility % | 43.05 | ||
14-Day RSI | 47.68 | ||
14-Day ATR (NT$) | 1.430564 | ||
20-Day SMA (NT$) | 20.505 | ||
12-1 Month Momentum % | -9.91 | ||
52-Week Range (NT$) | 14.4 - 29.25 | ||
Shares Outstanding (Mil) | 95.09 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Innopharmax Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Innopharmax Inc Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Innopharmax Inc Frequently Asked Questions
What is Innopharmax Inc(ROCO:4172)'s stock price today?
The current price of ROCO:4172 is NT$20.00. The 52 week high of ROCO:4172 is NT$29.25 and 52 week low is NT$14.40.
When is next earnings date of Innopharmax Inc(ROCO:4172)?
The next earnings date of Innopharmax Inc(ROCO:4172) is .
Does Innopharmax Inc(ROCO:4172) pay dividends? If so, how much?
Innopharmax Inc(ROCO:4172) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |